Global Medical REIT Inc. $GMRE Shares Sold by LDR Capital Management LLC

LDR Capital Management LLC lowered its holdings in shares of Global Medical REIT Inc. (NYSE:GMRE) by 91.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,846 shares of the company’s stock after selling 160,260 shares during the quarter. Global Medical REIT makes up 0.7% of LDR Capital Management LLC’s holdings, making the stock its 28th largest position. LDR Capital Management LLC’s holdings in Global Medical REIT were worth $500,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. AQR Capital Management LLC lifted its position in shares of Global Medical REIT by 9.5% during the 1st quarter. AQR Capital Management LLC now owns 58,538 shares of the company’s stock valued at $512,000 after buying an additional 5,062 shares in the last quarter. Jones Financial Companies Lllp lifted its holdings in Global Medical REIT by 23,920.0% during the first quarter. Jones Financial Companies Lllp now owns 24,020 shares of the company’s stock valued at $210,000 after purchasing an additional 23,920 shares in the last quarter. Goldman Sachs Group Inc. grew its position in shares of Global Medical REIT by 13.2% in the first quarter. Goldman Sachs Group Inc. now owns 388,605 shares of the company’s stock valued at $3,400,000 after purchasing an additional 45,243 shares during the period. Strs Ohio purchased a new stake in shares of Global Medical REIT during the first quarter worth about $95,000. Finally, State of Alaska Department of Revenue raised its position in shares of Global Medical REIT by 5.1% during the 2nd quarter. State of Alaska Department of Revenue now owns 30,876 shares of the company’s stock worth $213,000 after purchasing an additional 1,510 shares during the last quarter. 57.52% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

GMRE has been the topic of several research analyst reports. JMP Securities set a $40.00 price objective on Global Medical REIT and gave the stock a “market outperform” rating in a report on Monday, October 13th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Global Medical REIT in a research note on Monday, December 29th. Citizens Jmp raised Global Medical REIT from a “market perform” rating to an “outperform” rating and set a $40.00 price objective for the company in a research note on Monday, October 13th. Zacks Research raised shares of Global Medical REIT from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, September 24th. Finally, Wall Street Zen cut shares of Global Medical REIT from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $41.50.

Insider Buying and Selling

In other Global Medical REIT news, CEO Mark Okey Decker, Jr. purchased 10,000 shares of the firm’s stock in a transaction dated Friday, November 14th. The shares were acquired at an average price of $32.58 per share, with a total value of $325,800.00. Following the purchase, the chief executive officer directly owned 44,774 shares in the company, valued at approximately $1,458,736.92. This trade represents a 28.76% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. 8.50% of the stock is owned by corporate insiders.

Global Medical REIT Trading Down 0.5%

Shares of GMRE opened at $35.90 on Tuesday. Global Medical REIT Inc. has a 12-month low of $29.05 and a 12-month high of $45.75. The firm has a market capitalization of $481.42 million, a P/E ratio of -143.60 and a beta of 1.18. The firm has a 50-day moving average price of $33.81 and a 200 day moving average price of $34.19. The company has a current ratio of 0.52, a quick ratio of 0.52 and a debt-to-equity ratio of 1.65.

Global Medical REIT (NYSE:GMRE) last posted its earnings results on Tuesday, November 4th. The company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.07. Global Medical REIT had a net margin of 0.79% and a return on equity of 0.25%. The company had revenue of $37.23 million for the quarter, compared to analyst estimates of $38.15 million. Global Medical REIT has set its FY 2025 guidance at 4.500-4.600 EPS. Sell-side analysts forecast that Global Medical REIT Inc. will post 0.81 EPS for the current year.

Global Medical REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 9th. Shareholders of record on Friday, December 19th were paid a dividend of $0.75 per share. The ex-dividend date of this dividend was Friday, December 19th. This represents a $3.00 annualized dividend and a yield of 8.4%. Global Medical REIT’s dividend payout ratio (DPR) is -1,200.00%.

About Global Medical REIT

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.